Form 4: Cineverse CPO Mark Torres Reports Equity Holdings
Statement of Changes in Beneficial Ownership
Cineverse Corp.'s Chief People Officer, Mark Torres, filed a Form 4 detailing his beneficial ownership of Class A Common Stock, Stock Appreciation Rights, and Restricted Stock Units, including a new RSU grant.
Summary
- Mark Torres, Chief People Officer of Cineverse Corp. (CNVS), reported his beneficial ownership of company securities.
- He directly owns 158,274 shares of Class A Common Stock, which includes 66,667 restricted shares vesting in April 2026 and April 2027.
- Torres holds 8,334 Stock Appreciation Rights (SARs) with an exercise price of $39.4, fully vested by February 2024, expiring February 17, 2031.
- He also holds 12,500 SARs with an exercise price of $5.8, with vesting scheduled through May 2026, expiring May 16, 2033.
- The filing details 66,667 Restricted Stock Units (RSUs) vesting in April 2026 and April 2027.
- An additional 76,820 RSUs are held, vesting in May 2026, May 2027, and May 2028.
- A new grant of 66,763 RSUs was reported on October 8, 2025, vesting in October 2026, October 2027, and October 2028.
Sentiment
Score: 6
Explanation: Slightly positive due to the grant of new equity awards to a key executive, indicating continued incentive alignment and retention. No negative information is present.
Positives
- The grant of 66,763 Restricted Stock Units (RSUs) to the Chief People Officer aligns management incentives with shareholder value creation.
- Significant equity holdings by a key executive demonstrate commitment to the company's long-term success.
Future Outlook
The filing details future vesting schedules for various equity awards, indicating a long-term incentive structure for the Chief People Officer extending through October 2028.
Industry Context
This filing reflects standard executive compensation practices within the media and entertainment technology industry, where equity awards like Restricted Stock Units and Stock Appreciation Rights are common tools to align executive interests with long-term company performance and shareholder value.
Comparison to Industry Standards
- Equity compensation, including RSUs and SARs, is a standard practice for executive remuneration across publicly traded companies, particularly in the technology and media sectors.
- The vesting schedules, typically over several years, are consistent with industry norms designed to promote long-term retention and performance.
- Specific comparisons to other companies' CPO compensation would require detailed peer group analysis, which is beyond the scope of this Form 4 filing.
Stakeholder Impact
- Shareholders: Potential minor dilution from the future vesting of RSUs, but also improved alignment of executive incentives with long-term shareholder value.
- Employees: No direct impact on general employees, but reflects the company's executive compensation structure.
- Management: Mark Torres's compensation package is enhanced, providing long-term incentives and retention.
Next Steps
- Vesting of 33,333 restricted shares and 33,333 RSUs on April 25, 2026.
- Vesting of 25,607 RSUs on May 1, 2026.
- Vesting of 4,167 SARs on May 16, 2026.
- Vesting of 22,254 RSUs on October 8, 2026.
- Vesting of 33,334 restricted shares and 33,334 RSUs on April 25, 2027.
- Vesting of 25,607 RSUs on May 1, 2027.
- Vesting of 22,254 RSUs on October 8, 2027.
- Vesting of 25,606 RSUs on May 1, 2028.
- Vesting of 22,255 RSUs on October 8, 2028.
- Expiration of 8,334 SARs on February 17, 2031.
- Expiration of 12,500 SARs on May 16, 2033.
Key Dates
| Date | Description |
|---|---|
| 2022-02-17 | Vesting date for 2,778 Stock Appreciation Rights (SARs) with an exercise price of $39.4. |
| 2023-02-17 | Vesting date for 2,778 Stock Appreciation Rights (SARs) with an exercise price of $39.4. |
| 2024-02-17 | Vesting date for 2,778 Stock Appreciation Rights (SARs) with an exercise price of $39.4. |
| 2024-05-16 | Vesting date for 4,167 Stock Appreciation Rights (SARs) with an exercise price of $5.8. |
| 2025-05-16 | Vesting date for 4,167 Stock Appreciation Rights (SARs) with an exercise price of $5.8. |
| 2025-10-08 | Date of earliest transaction, representing the grant of 66,763 Restricted Stock Units (RSUs). |
| 2025-10-10 | Signature date of the reporting person for the Form 4 filing. |
| 2026-04-25 | Vesting date for 33,333 restricted shares of Class A Common Stock and 33,333 Restricted Stock Units (RSUs). |
| 2026-05-01 | Vesting date for 25,607 Restricted Stock Units (RSUs). |
| 2026-05-16 | Vesting date for 4,167 Stock Appreciation Rights (SARs) with an exercise price of $5.8. |
| 2026-10-08 | Vesting date for 22,254 Restricted Stock Units (RSUs) from the October 8, 2025 grant. |
| 2027-04-25 | Vesting date for 33,334 restricted shares of Class A Common Stock and 33,334 Restricted Stock Units (RSUs). |
| 2027-05-01 | Vesting date for 25,607 Restricted Stock Units (RSUs). |
| 2027-10-08 | Vesting date for 22,254 Restricted Stock Units (RSUs) from the October 8, 2025 grant. |
| 2028-05-01 | Vesting date for 25,606 Restricted Stock Units (RSUs). |
| 2028-10-08 | Vesting date for 22,255 Restricted Stock Units (RSUs) from the October 8, 2025 grant. |
| 2031-02-17 | Expiration date for 8,334 Stock Appreciation Rights (SARs) with an exercise price of $39.4. |
| 2033-05-16 | Expiration date for 12,500 Stock Appreciation Rights (SARs) with an exercise price of $5.8. |
Keywords
Cineverse Corp, CNVS, Mark Torres, Chief People Officer, SEC Form 4, Beneficial Ownership, Restricted Stock Units, Stock Appreciation Rights, Equity Compensation, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.